Desloratadine: all 57 studies that test it
Page 1 of 1. Open to participants first (6), then studies with results posted, then the rest; newest registration first within each.
- Multiple Adjunct Therapies to Improve Immunotherapy Treatment in Patients With Locally Advanced or Metastatic Melanoma or Advanced Hepatocellular CancerNot yet recruitingNCT07836712Phase 2
- Impact of the Antihistamine Desloratadine on the Quality of Life and Dysmenorrhea in Patients With EndometriosisNot yet recruitingNCT07821320Phase 2
- Desloratadine as Adjunct Therapy for Rheumatoid ArthritisRecruitingNCT07632872Phase 2
- Effect of Roflumilast and Desloratadine as Add-On Therapy in Patients With Rheumatoid ArthritisRecruitingNCT07566351Phase 2
- Desloratadine in Patients With Ulcerative ColitisRecruitingNCT07333716Phase 2
- Over-the-Counter Antihistamines & Heat StressRecruitingNCT06217367Phase 4
- Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Seasonal Allergic Rhinitis (MK-4117-204)CompletedNCT02320396Phase 3Results posted
- A Study of the Efficacy and Safety of Desloratadine (MK-4117) in Japanese Participants With Perennial Allergic Rhinitis (MK-4117-200)CompletedNCT01918033Phase 3Results posted
- Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Eczema/Dermatitis and Dermal Pruritus (MK-4117-202)CompletedNCT01916980Phase 3Results posted
- An Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Chronic Urticaria (MK-4117-201)CompletedNCT01916967Phase 3Results posted
- Multi-Center, Pediatric, Open-Label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec ® 5.0 mg Chewable Tablet Medications (Study P04573) (Completed)CompletedNCT00780403Phase 4Results posted
- Multi-center, Pediatric, Open-label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec 5.0 mg Chewable Tablet Medications (Study P04574)(COMPLETED)CompletedNCT00779116Phase 4Results posted
- The Duration of the Suppressive Effects of Desloratadine on Allergen Prick Tests After Discontinuation (P04441)CompletedNCT00359138Phase 4Results posted
- Antiplatelet Therapy in Chronic UrticariaActive, not recruitingNCT06268470Phase 2
- Role of Desloratadine in Reducing Inflammation From Occupational Heat StrainStatus unknownNCT05446480Not applicable
- Fixed Dose Combination of Desloratadine / Prednisolone in the Treatment of Moderate Severe Allergic Rhinitis in ChildrenCompletedNCT05214911Phase 3
- Influence of Antipruritics on the Dermal Blood Flow Response to Histamine, Cinnamaldehyde and Capsaicin.CompletedNCT04399148Not applicable
- Desloratadine,Phenylephrine Hcl,Ibuprofen Compared to Placebo in Treatment of Symptoms Associated With Common Cold/FluSuspendedNCT02904304Phase 3
- Anti-inflammatory H1 Antihistamines Allergic RhinitisCompletedNCT02507635Phase 4
- Anti-histamines and Methacholine Challenges.CompletedNCT01985789Phase 4
- Evaluation of the Inhibitory Effect of 5 Anti-Histamines in UrticariaCompletedNCT01940393Phase 4
- A Trial Evaluating Tolerability of Grazax Treatment in Combination With AntihistamineCompletedNCT01740284Phase 3
- Comparison of Desloratadine Associated With Prednisolone (Tablet)Versus Dexchlorpheniramine Associated With Betamethasone (Tablet) for Adult Persistent Allergic Rhinitis TreatmentStatus unknownNCT01720485Phase 3
- Comparison of Desloratadine Associated With Prednisolone Oral Solution Versus Dexchlorpheniramine Associated With Betamethasone for Cutaneous Rash TreatmentTerminatedNCT01529242Phase 3
- Comparison of Desloratadine Associated With Prednisolone Oral Solution Versus Dexchlorpheniramine Associated With Betamethasone for Persistent Allergic Rhinitis TreatmentCompletedNCT01529229Phase 3
- Bioequivalence Study of Desloratadine and Pseudoephedrine Extended-release Tablets Under Fed ConditionsCompletedNCT01506791Phase 1
- Bioequivalence Study for Desloratadine OD Tablets 5 mg Under Fasting ConditionCompletedNCT01506050Phase 1
- Bioequivalence Study for Desloratadine OD Tablets 5 mg Under Fed ConditionCompletedNCT01506037Phase 1
- Desloratadine 5, 10 and 20mg in Patients With Cold UrticariaCompletedNCT01444196Phase 4
- Bioequivalence Study of Desloratadine and Pseudoephedrine Sulfate Extended-release Tablets Under Fasting ConditionsCompletedNCT01373138Phase 1
- Bioavailability Study of Desloratadine 5 mg Tablet of Dr. Reddy's Under Fed ConditionsCompletedNCT01314352Phase 1
- Bioavailability Study of Dr. Reddy's Desloratadine Tablets, 5 mg Under Fasting Conditions.CompletedNCT01314339Phase 1
- Comparison of the Effects of Desloratadine and Placebo in the Relief of Nasal Symptom Scores in Subjects With Seasonal Allergic Rhinitis to Cypress Pollen (Study P02836)CompletedNCT00867191Phase 4
- Study of the Effectiveness and Safety of Desloratadine (Aerius) Syrup in Children With Allergic Skin Inflammation (P03475)CompletedNCT00817076Phase 3
- Desloratadine With Oxybutynin for the Treatment of Seasonal Allergic Rhinitis and Post-Nasal Drip (Study P04258)(COMPLETED)CompletedNCT00816972Phase 2
- Study of Nasal Symptom Relief and Side Effects in Hayfever Patients Treated With Aerius (Desloratadine)(P03442)CompletedNCT00805584Phase 4
- Study of the Effectiveness and Safety of Desloratadine (Aerius) Syrup in Children With Hayfever With or Without Asthma (P03472)CompletedNCT00805324Phase 3
- An Open-Label Study of the Effects of Desloratadine (Aerius.) Treatment on the Quality of Life of Patients With Chronic Idiopathic Urticaria (Study P02540)CompletedNCT00795522Phase 4
- How Desloratadine (Clarinex, Aerius) Affects Quality of Life in Patients With Chronic Idiopathic Urticaria (Have Had Hives for 6 Weeks or Longer)(Study P02988)CompletedNCT00795158Phase 3
- Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03180)CompletedNCT00794846Phase 4
- Taste Test Between Desloratadine and Cetirizine Syrup in Children (Study P03826)CompletedNCT00794794Phase 3
- Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03182)CompletedNCT00794599Phase 4
- Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03181)CompletedNCT00794495Phase 4
- Taste Test Between Desloratadine and Cetirizine Syrup in Children (Study P03829)(COMPLETED)CompletedNCT00794378Phase 3
- The Effect of Desloratadine and Levocetirizine on Nasal Obstruction (Study P03609)CompletedNCT00789152Phase 3
- A Comparison of Aerius Continuous Treatment Versus Aerius PRN for Chronic Idiopathic Urticaria (Study P03147)CompletedNCT00783354Phase 4
- Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR)(Study P04053)(COMPLETED)CompletedNCT00783211Phase 4
- Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR) (Study P04054)CompletedNCT00783146Phase 4
- Effectiveness and Safety of Desloratadine in Patients With Allergic Airway Disease During the Pollen Season (Study P03284)CompletedNCT00779636Phase 4
- Safety of Desloratadine in Children With Allergy Sensitivity and Chronic Hives, Who Are Poor Metabolizers of Desloratadine (Study P02994)CompletedNCT00757562Phase 3
- A Comparative Double-Blind, Double- Dummy Study of Desloratadine (DL) 5 MG Once Daily, Cetirizine 10 MG Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03735)CompletedNCT00751218Phase 4
- A Comparative Double-blind, Double-dummy Study of Desloratadine (DL) 5 mg Once Daily, Cetirizine 10 mg Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03736)TerminatedNCT00751166Phase 4
- A Study to Assess and Compare the Effects of 5 mg vs. 20 mg Desloratadine on the Development of Cold Urticaria LesionsCompletedNCT00600847Phase 4
- Effects of 5 mg vs. 20 mg Desloratadine on Skin Lesions in Patients With Chronic Urticaria (CU)CompletedNCT00598611Phase 3
- Airway Responses to Montelukast and Desloratadine.CompletedNCT00424580Not applicable
- The Efficacy and Safety of Desloratadine With Levocetirizine in Treatment of Chronic Idiopathic UrticariaStatus unknownNCT00346606Phase 4
- A Study of the Effects of Desloratadine on Conjunctival Allergen Challenge-induced Ocular Signs and Symptoms (Study P04209)CompletedNCT00311844Phase 4